Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 301 | $78.95M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 302 | $78.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 303 | $78.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 304 | $77.72M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 305 | $77.32M | Healthcare | Medical Devices | United States | NYSE |
| 306 | $76.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 307 | $75.67M | Healthcare | Biotechnology | United States | Nasdaq |
| 308 | $73.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 309 | $73.85M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 310 | $73.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 311 | $72.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 312 | $72.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 313 | $71.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 314 | $71.16M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 315 | $70.37M | Healthcare | Biotechnology | United States | Nasdaq |
| 316 | $70.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 317 | $70.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 318 | $69.85M | Healthcare | Medical Devices | United States | Nasdaq |
| 319 | $69.70M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 320 | $68.56M | Healthcare | Medical Devices | United States | Nasdaq |
| 321 | $68.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 322 | $67.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 323 | $67.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 324 | $65.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 325 | $64.59M | Healthcare | Medical Devices | United States | Nasdaq |
| 326 | $64.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 327 | $64.11M | Healthcare | Biotechnology | United States | Nasdaq |
| 328 | $63.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 329 | $63.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 330 | $63.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 331 | $63.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 332 | $63.02M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 333 | $63.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 334 | $62.82M | Healthcare | Medical Devices | United States | Nasdaq |
| 335 | $62.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 336 | $62.12M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 337 | $61.96M | Healthcare | Biotechnology | USA | Nasdaq |
| 338 | $61.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 339 | $61.41M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 340 | $61.00M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 341 | $60.32M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 342 | $59.91M | Healthcare | Biotechnology | United States | Nasdaq |
| 343 | $59.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 344 | $59.08M | Healthcare | Medical Devices | United States | Nasdaq |
| 345 | $57.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 346 | $56.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 347 | $56.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 348 | $55.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 349 | $55.84M | Healthcare | Medical Devices | United States | Nasdaq |
| 350 | $55.65M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 351 | $55.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 352 | $54.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 353 | $54.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 354 | $54.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 355 | $54.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 356 | $54.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 357 | $53.98M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 358 | $53.86M | Healthcare | Medical Devices | United States | Nasdaq |
| 359 | $53.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 360 | $52.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 361 | $52.09M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 362 | $51.38M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 363 | $50.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 364 | $50.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 365 | $49.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 366 | $49.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 367 | $48.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 368 | $48.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 369 | $47.96M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 370 | $47.52M | Healthcare | Medical Devices | United States | Nasdaq |
| 371 | $46.24M | Healthcare | Medical Devices | United States | Nasdaq |
| 372 | $46.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 373 | $45.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 374 | $45.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 375 | $44.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 376 | $44.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 377 | $44.32M | Healthcare | Medical Devices | United States | Nasdaq |
| 378 | $44.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 379 | $44.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 380 | $43.46M | Healthcare | Medical Devices | United States | Nasdaq |
| 381 | $43.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 382 | $43.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 383 | $42.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 384 | $42.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 385 | $41.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 386 | $41.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 387 | $41.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 388 | $41.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 389 | $41.25M | Healthcare | Biotechnology | United States | Nasdaq |
| 390 | $41.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 391 | $41.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 392 | $41.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 393 | $40.62M | Healthcare | Medical Devices | United States | Nasdaq |
| 394 | $39.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 395 | $39.21M | Healthcare | Healthcare Providers | United States | NYSE |
| 396 | $38.63M | Healthcare | Biotechnology | United States | Nasdaq |
| 397 | $38.41M | Healthcare | Medical Devices | United States | Nasdaq |
| 398 | $38.27M | Healthcare | Medical Devices | United States | Nasdaq |
| 399 | $37.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 400 | $37.33M | Healthcare | Medical Devices | United States | NYSE |
U.S.-exchange common stocks; ADRs and funds excluded. 685 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.